Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
BIOMAKERSBiotech · United StatesCompany profile

BIOMAKERS analyzes clinical and genomic information.

BIOMAKERS analyzes clinical and genomic information.

$8MUndisclosedBiotechUnited StatesInvestors
CancilicoHealthtech · GermanyCompany profile

Cancilico develops AI diagnostic software for hematology.

Cancilico develops AI diagnostic software for hematology.

€2.5MSeedBiotech, HealthtechGermanyInvestors
Anzen IndustriesBiotech · United StatesCompany profile

Anzen Industries, now operating as Tera, develops modular cell-free enzyme reactors for manufacturing high-value chemicals.

Anzen Industries, now operating as Tera, develops modular cell-free enzyme reactors for manufacturing high-value chemicals.

$2.2MPre-seedBiotechUnited StatesInvestors
CytotheryxBiotech · United StatesCompany profile

Develops cell therapy platform for liver disease

Develops cell therapy platform for liver disease

$60MSeries ABiotechUnited StatesInvestors
SableBiotech · United StatesCompany profile

Develops high-performance topical solutions for body contouring and sustained aesthetic results

Develops high-performance topical solutions for body contouring and sustained aesthetic results

UndisclosedPre-SeedPre-seedBiotechUnited StatesInvestors
Transition Metal SolutionsIndustrial tech · United StatesCompany profile

Develops custom chemical additives to enhance wild microbial communities for metal extraction

Develops custom chemical additives to enhance wild microbial communities for metal extraction

$6MSeedBiotech, Industrial techUnited StatesInvestors
Caldera TherapeuticsBiotech · United StatesCompany profile

Develops bispecific antibody CLD-423 for inflammatory bowel disease

Develops bispecific antibody CLD-423 for inflammatory bowel disease

$37.5MSeries A1Series ABiotechUnited StatesInvestors
RISA LabsAI · United StatesCompany profile

Develops AI operating system for oncology workflows

Develops AI operating system for oncology workflows

$11.1MSeries ABiotech, AIUnited StatesInvestors
Axol BioscienceBiotech · United KingdomCompany profile

Provider of human induced pluripotent stem cell (iPSC) technologies

Provider of human induced pluripotent stem cell (iPSC) technologies

$2.8MUndisclosedBiotechUnited KingdomInvestors
Vivere OncotherapiesBiotech · United StatesCompany profile

Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells.

Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells.

$10MSeries ABiotechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic